Stryker Steps up to the Plate at Chickasaw Bricktown Ballpark with Its SmartRobotics™ Technology

Today, Stryker makes a stop with its “SmartRobotics™ Stadium” booth at Chickasaw Bricktown Ballpark in Oklahoma City as part of its 10-city tour in partnership with Minor League Baseball™ (MiLB™).

On July 22 and July 23, Dodgers fans are encouraged to come out to a ballgame and see the latest innovation in joint replacement technology, Mako SmartRobotics™, on full display in the stadium. Stryker will also have fun, interactive activities between innings, as well as local orthopaedic surgeons on-site to speak about joint health and treatment options, including Mako SmartRobotics™ robotic-arm assisted surgery.

“As we emerge from the pandemic, it will be encouraging to see fans back in the stands cheering on the Dodgers as they take on the Sugar Land Skeeters,” said Don Payerle, president of Stryker’s Joint Replacement division. “We hope they take the opportunity to stop by our SmartRobotics™ Stadium and learn about the ways Stryker can help with knee and hip pain that may have been left untreated during the pandemic.”

Fans can learn more about Stryker throughout the games with videoboard commercials and promotions, including a seat upgrade for a lucky fan. In addition to the game day events, local Mako-certified orthopaedic surgeons will be back at the ballpark on Monday, August 9, for an educational seminar about joint health, the latest technologies available and surgical and nonsurgical options available to patients.

Elective Surgeries Are Back in the Lineup

The pandemic forced many individuals and their physicians to delay necessary orthopaedic procedures, which can result in increased use of medications, a more difficult recovery and more complicated surgeries, according to a recent Lancet study.1 Now that many communities are fully open again, it is important for those living with joint pain to revisit their treatment plans and for healthcare professionals to educate them on their options to help prevent further pain and complications.

Individuals are encouraged to come out to the Chickasaw Bricktown Ballpark and learn about new advancements designed to keep those with joint pain active, including Mako SmartRobotics™ technology. Fans can visit the SmartRobotics™ Stadium booth near the Mickey Mantle Gate. To register for the seminar and learn more about joint health treatment options, please visit here.

Lastly, as part of its “Own the Walk” charitable program, Stryker will donate $1 to K9s For Warriors – the nation’s largest provider of service dogs to American veterans living with military-related trauma – for every walk issued to a batter during the regular season. Stryker has been a committed partner of K9s For Warriors since 2015, having sponsored 31 service dogs to date — the largest number by any corporate partner.

All surgery carries risk. See your orthopaedic surgeon to discuss your potential benefits and risks. Not all patients will have the same postoperative recovery and activity level. Individual results vary.

Originally reported here.

 

SourceStryker

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”